This further supports the ideas that miR-29b influence BC metastasis mainly through targeting TET1 and that TET1 plays a crucial role in EMT regulation, which explains the observation that low levels of miR-29b in BC patients promotes breast cancer development. The gene discussed is TET1; the disease is breast cancer.